On Invalid Date, Imv (NASDAQ: IMV) reported Q3 2022 earnings per share (EPS) of -$0.08, up 18.63% year over year. Total Imv earnings for the quarter were -$6.77 million. In the same quarter last year, Imv's earnings per share (EPS) was -$0.10.
As of Q4 2022, Imv's earnings has grown year over year. Imv's earnings in the past year totalled -$30.00 million.
What was IMV's revenue last quarter?
On Invalid Date, Imv (NASDAQ: IMV) reported Q3 2022 revenue of $89.39 thousand up 176.9% year over year. In the same quarter last year, Imv's revenue was $32.28 thousand.
What was IMV's revenue growth in the past year?
As of Q4 2022, Imv's revenue has grown -7.72% year over year. This is 125.18 percentage points lower than the US Biotechnology industry revenue growth rate of 117.46%. Imv's revenue in the past year totalled $154.01 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.